Sepsis is the body’s extreme reaction to an infection. It causes 11 million deaths annually and is a global health priority affecting 55 million patients worldwide annually. Treatment for sepsis ...

Of all the life-threatening conditions hospitals battle on a daily basis, sepsis is a particularly fickle beast. Despite the difficulties associated with diagnosing this complication, healthcare ...

A long-awaited study of septic shock treatments has found that expensive and risky parts of a widely accepted resuscitation protocol now in place in many hospitals do not improve outcomes when ...

A new study published in the Journal of American Medical Association showed that for the key composite outcome in early ...

Sepsis, a common and potentially deadly complication to an infection, is the leading cause of death in U.S. hospitals, accounting for 35% of in-hospital deaths. But as many as 87% of sepsis cases ...

Inotrem and Roche’s diagnostics division have upgraded their years-long collaboration on a plasma test for septic shock, with a new worldwide licensing agreement. The France-based Inotrem secured the ...

SYDNEY--(BUSINESS WIRE)--Australian clinical-stage drug development company Noxopharm Limited (ASX:NOX) announced an international patent application aimed at protecting the use of experimental ...

The incidence of sepsis (and death from septic shock) is increasing, and treatments are still inadequate. Now a study in Science offers promise for a new treatment option involving blockade of ...

Patients with heart failure frequently suffer from fluid overload, and for those with heart failure with reduced ejection fraction (HFrEF) also suffering from septic shock—a condition often treated ...

Funding from a U.S.-Israeli fund will support advanced preclinical and Phase I testing. Fast-Track Drugs & Biologics and Atox Bio, a spin-out of the Hebrew University of Jerusalem, won a $575,000 ...

Please provide your email address to receive an email when new articles are posted on . The 30-day mortality benefit of sepsis antibiotic treatment within 3 hours was larger in some patient ...

Craig Lilly, MD, a pulmonary medicine and critical care specialist at the University of Massachusetts Memorial Medical Center, who was not one of the trial results authors, reacted to the study. "This ...